Bioactivity and Vitamins in Flash-heated Breastmilk

快速加热母乳中的生物活性和维生素

基本信息

项目摘要

DESCRIPTION (provided by applicant): Breastfeeding contributes to maternal to child transmission of HIV, which is responsible for 90% of the 800,000 HIV infections that occur each year among the world's children, the vast majority of which are in sub-Saharan Africa. Current UNICEF/WHO recommendations focus on the challenge of making breastfeeding safer; guidelines include heat treatment of breastmilk as an official infant feeding recommendation for HIV positive mothers in developing countries. This study will evaluate nutritional and bacteriologic safety of home pasteurized breastmilk. This information is necessary to adequately inform mothers of risks and benefits of this feeding alternative. The overall objective of this study is to scientifically evaluate the effect of Flash-heat (a method mothers can perform at home to inactivate HIV) on nutrient, immunologic and anti-infective components of breastmilk. Heated milk must be nutritious enough to support growth and development, retain anti-infective activity in order to prevent infectious morbidities. Specific aims include evaluation of impact of Flash-heat on the following aspects of breastmilk samples from HIV-infected mothers: 1) vitamin content and protein digestibility; 2) key bioactive proteins (immunoglobulin A, lysozyme and lactoferrin); 3) antibacterial activity. Specific aim 3 is to determine dietary needs of African infants of different ages receiving heat-treated milk. 50 breastmilk samples have been previously collected from South African women who are HIVpositive, and Flash-heated. In the available aliquots of heated and unheated milk we will measure and compare: a) concentrations of vitamins A, ascorbic acid, thiamine, riboflavin, pyridoxine, folate and B12, known to be relatively heat-sensitive; b) concentration and digestability of proteins lysozyme and lactoferrin; c) concentration of total and slgA and bioactivity (via binding) of each against specific antigens (measles, S. pneumoniae, influenza); d) bioactivity of isolated anti-infective proteins lactoferrin and lysozyme, via uptake into cells, enzymatic and bactericidal activity; e) antibacterial properties of milk via inhibition of growth of E. coli and S. aureus over time. Information from these analyses will be used in linear programming to predict how the described changes in nutrient content of milk due to heating would affect the overall dietary needs of the child and the associated costs.
描述(由申请人提供):母乳喂养有助于孕产妇的艾滋病毒传播,这是全球儿童中每年发生的800,000名艾滋病毒感染中的90%,其中绝大多数在撒哈拉以南非洲。联合国儿童基金会/世界卫生组织的建议集中于使母乳喂养更安全的挑战;指南包括对母乳的热处理作为对发展中国家的艾滋病毒阳性母亲的官方婴儿喂养建议。这项研究将评估家庭巴氏杀菌母乳的营养和细菌学安全。这些信息是必要的,以充分告知母亲这种喂养替代方案的风险和好处。这项研究的总体目的是科学评估闪光热(母亲可以在家中以抗活艾滋病毒而执行的方法)对母乳的营养,免疫和抗感染成分的影响。加热牛奶必须足够营养以支持生长和发育,保留抗感染活性,以防止感染性病。具体目的包括评估闪光灯对艾滋病毒感染母亲的母乳样本以下方面的影响:1)维生素含量和蛋白质消化率; 2)关键生物活性蛋白(免疫球蛋白A,溶菌酶和乳铁蛋白); 3)抗菌活性。具体目的3是确定接受热处理牛奶的不同年龄的非洲婴儿的饮食需求。以前已经从Hivpostitive且闪烁的南非妇女那里收集了50个母乳样本。在加热和未加热的牛奶的可用等分试样中,我们将测量和比较:a)维生素A,抗坏血酸,硫胺素,核黄素,吡啶还醇,叶酸和B12的浓度,已知是相对敏感的; b)蛋白质溶菌酶和乳铁蛋白的浓度和浓度; c)每种浓度(通过结合)与特定抗原(麻疹,肺炎,流感)的浓度(通过结合); d)分离的抗感染蛋白乳铁蛋白和溶菌酶的生物活性,通过摄取细胞,酶促和杀菌活性; E)随着时间的推移,牛奶的抗菌特性通过抑制大肠杆菌和金黄色葡萄球菌的生长。这些分析中的信息将用于线性编程中,以预测牛奶中所描述的牛奶含量变化如何影响儿童的整体饮食需求和相关成本。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

CAROLINE J CHANTRY的其他基金

Planning a clinical trial of Flash-heated breast milk to decrease morbidity, impr
计划进行快速加热母乳的临床试验以降低发病率、影响
  • 批准号:
    7928643
    7928643
  • 财政年份:
    2010
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别:
Feasibility and Pilot Efficacy of Flash-heated Breastmilk to Reduce Pediatric HIV
快速加热母乳减少儿童艾滋病毒感染的可行性和试点效果
  • 批准号:
    7502673
    7502673
  • 财政年份:
    2007
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别:
Feasibility and Pilot Efficacy of Flash-heated Breastmilk to Reduce Pediatric HIV
快速加热母乳减少儿童艾滋病毒感染的可行性和试点效果
  • 批准号:
    7387545
    7387545
  • 财政年份:
    2007
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别:

相似海外基金

Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
  • 批准号:
    10761853
    10761853
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别:
Designing an Ethnodrama Intervention Addressing PrEP Stigma Toward Young Women
设计民族戏剧干预措施,解决针对年轻女性的 PrEP 耻辱
  • 批准号:
    10755777
    10755777
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别:
The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk.
COVID-19 时代艾滋病毒的面貌不断变化:通过动态定位当前和未来的感染风险分布,最大限度地降低艾滋病毒发病率。
  • 批准号:
    10548290
    10548290
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别:
MyPrEP Plus: Development and Pilot Testing of Novel Pre-Exposure Prophylaxis Support Tools for Transgender Women
MyPrEP Plus:针对跨性别女性的新型暴露前预防支持工具的开发和试点测试
  • 批准号:
    10618102
    10618102
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别:
Sustained Release of Potent Antiviral Prodrugs for HIV Prevention
持续释放有效的抗病毒前药以预防艾滋病毒
  • 批准号:
    10617540
    10617540
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
    $ 25.47万
  • 项目类别: